1 |
SINHA D, PRASAD P. Health effects inflicted by chronic low-level arsenic contamination in groundwater: a global public health challenge[J]. J Appl Toxicol, 2020, 40(1): 87-131.
|
2 |
AHMAD S A, KHAN M H, HAQUE M. Arsenic contamination in groundwater in Bangladesh: implications and challenges for healthcare policy[J]. Risk Manag Healthc Policy, 2018, 11: 251-261.
|
3 |
GONZÁLEZ-HORTA C, BALLINAS-CASARRUBIAS L, SÁNCHEZ-RAMÍREZ B, et al. A concurrent exposure to arsenic and fluoride from drinking water in Chihuahua, Mexico[J]. Int J Environ Res Public Health, 2015, 12(5): 4587-4601.
|
4 |
RODRÍGUEZ-LADO L, SUN G F, BERG M, et al. Groundwater arsenic contamination throughout China[J]. Science, 2013, 341(6148): 866-868.
|
5 |
ALONSO D L, LATORRE S, CASTILLO E, et al. Environmental occurrence of arsenic in Colombia: a review[J]. Environ Pollut, 2014, 186: 272-281.
|
6 |
HUANG L, WU H Y, VAN DER KUIJP T J. The health effects of exposure to arsenic-contaminated drinking water: a review by global geographical distribution[J]. Int J Environ Health Res, 2015, 25(4): 432-452.
|
7 |
NELSON G M, AHLBORN G J, ALLEN J W, et al. Transcriptional changes associated with reduced spontaneous liver tumor incidence in mice chronically exposed to high dose arsenic[J]. Toxicology, 2009, 266(1/2/3): 6-15.
|
8 |
SMITH A H, MARSHALL G, YUAN Y, et al. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood[J]. Environ Health Perspect, 2006, 114(8): 1293-1296.
|
9 |
CHEN C J, CHEN C W, WU M M, et al. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water[J]. Br J Cancer, 1992, 66(5): 888-892.
|
10 |
International Agency for Research on Cancer. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans[R]. Lyons: World Health Organization, International Agency for Research on Cancer, 1982.
|
11 |
LI S, HONG M, TAN H Y, et al. Insights into the role and interdependence of oxidative stress and inflammation in liver diseases[J]. Oxid Med Cell Longev, 2016, 2016: 4234061.
|
12 |
WAALKES M P, LIU J, WARD J M, et al. Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice[J]. Toxicol Appl Pharmacol, 2004, 198(3): 377-384.
|
13 |
SADAF N, KUMAR N, ALI M, et al. Arsenic trioxide induces apoptosis and inhibits the growth of human liver cancer cells[J]. Life Sci, 2018, 205: 9-17.
|
14 |
SANTRA A, MAITI A, CHOWDHURY A, et al. Oxidative stress in liver of mice exposed to arsenic-contaminated water[J]. Indian J Gastroenterol, 2000, 19(3): 112-115.
|
15 |
DITZEL E J, LI H, FOY C E, et al. Altered hepatic transport by fetal arsenite exposure in diet-induced fatty liver disease[J]. J Biochem Mol Toxicol, 2016, 30(7): 321-330.
|
16 |
DITZEL E J, NGUYEN T, PARKER P, et al. Effects of arsenite exposure during fetal development on energy metabolism and susceptibility to diet-induced fatty liver disease in male mice[J]. Environ Health Perspect, 2016, 124(2): 201-209.
|
17 |
CAO M Q, YOU A B, CUI W, et al. Cross talk between oxidative stress and hypoxia via thioredoxin and HIF-2α drives metastasis of hepatocellular carcinoma[J]. FASEB J, 2020, 34(4): 5892-5905.
|
18 |
ZHANG C, ZHAO J, ZHAO J, et al. CYP2E1-dependent upregulation of SIRT7 is response to alcohol mediated metastasis in hepatocellular carcinoma[J]. Cancer Gene Ther, 2022: 2022Jul28.
|
19 |
戴翔宇, 陈超, 王大朋, 等. 缺氧诱导因子1α在砷所致人肝细胞上皮间质转化及其恶性转化中的作用[J].中华预防医学杂志, 2018, 52(10): 988-993.
|
|
DAI X Y, CHEN C, WANG D P, et al. Hypoxia-inducible factor-1α is involved in arsenite-induced epithelial-mesenchymal transition and malignant transformation of human liver epithelial cells via regulating Snail[J]. Chin J Prev Med, 2018, 52(10): 988-993.
|
20 |
LEE H Y, NGA H T, TIAN J W, et al. Mitochondrial metabolic signatures in hepatocellular carcinoma[J]. Cells, 2021, 10(8): 1901.
|
21 |
HSUEH Y M, CHIOU H Y, HUANG Y L, et al. Serum β-carotene level, arsenic methylation capability, and incidence of skin cancer[J]. Cancer Epidemiol Biomarkers Prev, 1997, 6(8): 589-596.
|
22 |
NURCHI V M, DJORDJEVIC A B, CRISPONI G, et al. Arsenic toxicity: molecular targets and therapeutic agents[J]. Biomolecules, 2020, 10(2): 235.
|
23 |
YU D. A physiologically based pharmacokinetic model of inorganic arsenic[J]. Regul Toxicol Pharmacol, 1999, 29(2 Pt 1): 128-141.
|
24 |
PERSON R J, NGALAME N N, MAKIA N L, et al. Chronic inorganic arsenic exposure in vitro induces a cancer cell phenotype in human peripheral lung epithelial cells[J]. Toxicol Appl Pharmacol, 2015, 286(1): 36-43.
|
25 |
SUN J, SHI L, XIAO T, et al. microRNA-21, via the HIF-1α/VEGF signaling pathway, is involved in arsenite-induced hepatic fibrosis through aberrant cross-talk of hepatocytes and hepatic stellate cells[J]. Chemosphere, 2021, 266: 129177.
|
26 |
PAN X J, DAI Y J, LI X, et al. Inhibition of arsenic-induced rat liver injury by grape seed exact through suppression of NADPH oxidase and TGF-β/Smad activation[J]. Toxicol Appl Pharmacol, 2011, 254(3): 323-331.
|
27 |
LEE K M, HWANG M K, LEE D E, et al. Protective effect of quercetin against arsenite-induced COX-2 expression by targeting PI3K in rat liver epithelial cells[J]. J Agric Food Chem, 2010, 58(9): 5815-5820.
|
28 |
WANG W J, CHENG S, ZHANG D F. Association of inorganic arsenic exposure with liver cancer mortality: a meta-analysis[J]. Environ Res, 2014, 135: 120-125.
|
29 |
SANTRA A, MAITI A, DAS S, et al. Hepatic damage caused by chronic arsenic toxicity in experimental animals[J]. J Toxicol Clin Toxicol, 2000, 38(4): 395-405.
|
30 |
SINHA D, PRASAD P. Health effects inflicted by chronic low-level arsenic contamination in groundwater: a global public health challenges[J]. J Appl Toxicol, 2020,40(1): 87-131.
|
31 |
HU Y Y, WANG S P, WANG A Q, et al. Antioxidant and hepatoprotective effect of Penthorum chinense Pursh extract against t-BHP-induced liver damage in L02 cells[J]. Molecules, 2015, 20(4): 6443-6453.
|
32 |
LI S, TAN H Y, WANG N, et al. The role of oxidative stress and antioxidants in liver diseases[J]. Int J Mol Sci, 2015, 16(11): 26087-26124.
|
33 |
MARTNER A, AYDIN E, HELLSTRAND K. NOX2 in autoimmunity, tumor growth and metastasis[J]. J Pathol, 2019, 247(2): 151-154.
|
34 |
金子林, 郭锡熔, 周旭华, 等. MAPK8基因在小鼠源性3T3-L1脂肪细胞诱导分化中表达水平的变化[J]. 中国儿童保健杂志, 2004, 12(4): 327-329.
|
|
JIN Z L, GUO X R, ZHOU X H, et al. Changes of MAPK8 gene expression during mouse 3T3-L1preadipocyte differentiation[J]. Chin J Child Health Care, 2004, 12(4): 327-329.
|